This will include the return of the 702-hp TRX and a rumored V8-powered RHO.
Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback